S-nitrosothiol repletion by an inhaled gas regulates pulmonary function

Martin P. Moya, Andrew J. Gow, Timothy J. McMahon, Eric J. Toone, Ira M. Cheifetz, Ronald N. Goldberg, Jonathan S. Stamler

Результат исследований: Материалы для журналаСтатья

57 Цитирования (Scopus)

Выдержка

NO synthases are widely distributed in the lung and are extensively involved in the control of airway and vascular homeostasis. It is recognized, however, that the O2-rich environment of the lung may predispose NO toward toxicity. These Janus faces of NO are manifest in recent clinical trials with inhaled NO gas, which has shown therapeutic benefit in some patient populations but increased morbidity in others. In the airways and circulation of humans, most NO bioactivity is packaged in the form of S-nitro-sothiols (SNOs), which are relatively resistant to toxic reactions with O2/O2 -. This finding has led to the proposition that channeling of NO into SNOs may provide a natural defense against lung toxicity. The means to selectively manipulate the SNO pool, however, has not been previously possible. Here we report on a gas, O-nitrosoethanol (ENO), which does not react with O2 or release NO and which markedly increases the concentration of indigenous species of SNO within airway lining fluid. Inhalation of ENO provided immediate relief from hypoxic pulmonary vasoconstriction without affecting systemic hemodynamics. Further, in a porcine model of lung injury, there was no rebound in cardiopulmonary hemodynamics or fall in oxygenation on stopping the drug (as seen with NO gas), and additionally ENO protected against a decline in cardiac output. Our data suggest that SNOs within the lung serve in matching ventilation to perfusion, and can be manipulated for therapeutic gain. Thus, ENO may be of particular benefit to patients with pulmonary hypertension, hypoxemia, and/or right heart failure, and may offer a new therapeutic approach in disorders such as asthma and cystic fibrosis, where the airways may be depleted of SNOs.

Язык оригиналаАнглийский
Страницы (с-по)5792-5797
Число страниц6
ЖурналProceedings of the National Academy of Sciences of the United States of America
Том98
Номер выпуска10
DOI
СостояниеОпубликовано - 8 мая 2001
Опубликовано для внешнего пользованияДа

Отпечаток

S-Nitrosothiols
Gases
Lung
Hemodynamics
Airway Management
Poisons
Lung Injury
Vasoconstriction
Pulmonary Hypertension
Cystic Fibrosis
Nitric Oxide Synthase
Cardiac Output
Inhalation
Blood Vessels
Ventilation
Homeostasis
Swine
Therapeutics
Asthma
Heart Failure

ASJC Scopus subject areas

  • Genetics
  • General

Цитировать

Moya, M. P., Gow, A. J., McMahon, T. J., Toone, E. J., Cheifetz, I. M., Goldberg, R. N., & Stamler, J. S. (2001). S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proceedings of the National Academy of Sciences of the United States of America, 98(10), 5792-5797. https://doi.org/10.1073/pnas.091109498

S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. / Moya, Martin P.; Gow, Andrew J.; McMahon, Timothy J.; Toone, Eric J.; Cheifetz, Ira M.; Goldberg, Ronald N.; Stamler, Jonathan S.

В: Proceedings of the National Academy of Sciences of the United States of America, Том 98, № 10, 08.05.2001, стр. 5792-5797.

Результат исследований: Материалы для журналаСтатья

Moya, MP, Gow, AJ, McMahon, TJ, Toone, EJ, Cheifetz, IM, Goldberg, RN & Stamler, JS 2001, 'S-nitrosothiol repletion by an inhaled gas regulates pulmonary function', Proceedings of the National Academy of Sciences of the United States of America, том. 98, № 10, стр. 5792-5797. https://doi.org/10.1073/pnas.091109498
Moya, Martin P. ; Gow, Andrew J. ; McMahon, Timothy J. ; Toone, Eric J. ; Cheifetz, Ira M. ; Goldberg, Ronald N. ; Stamler, Jonathan S. / S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. В: Proceedings of the National Academy of Sciences of the United States of America. 2001 ; Том 98, № 10. стр. 5792-5797.
@article{b48089673da04163a51630102112f67a,
title = "S-nitrosothiol repletion by an inhaled gas regulates pulmonary function",
abstract = "NO synthases are widely distributed in the lung and are extensively involved in the control of airway and vascular homeostasis. It is recognized, however, that the O2-rich environment of the lung may predispose NO toward toxicity. These Janus faces of NO are manifest in recent clinical trials with inhaled NO gas, which has shown therapeutic benefit in some patient populations but increased morbidity in others. In the airways and circulation of humans, most NO bioactivity is packaged in the form of S-nitro-sothiols (SNOs), which are relatively resistant to toxic reactions with O2/O2 -. This finding has led to the proposition that channeling of NO into SNOs may provide a natural defense against lung toxicity. The means to selectively manipulate the SNO pool, however, has not been previously possible. Here we report on a gas, O-nitrosoethanol (ENO), which does not react with O2 or release NO and which markedly increases the concentration of indigenous species of SNO within airway lining fluid. Inhalation of ENO provided immediate relief from hypoxic pulmonary vasoconstriction without affecting systemic hemodynamics. Further, in a porcine model of lung injury, there was no rebound in cardiopulmonary hemodynamics or fall in oxygenation on stopping the drug (as seen with NO gas), and additionally ENO protected against a decline in cardiac output. Our data suggest that SNOs within the lung serve in matching ventilation to perfusion, and can be manipulated for therapeutic gain. Thus, ENO may be of particular benefit to patients with pulmonary hypertension, hypoxemia, and/or right heart failure, and may offer a new therapeutic approach in disorders such as asthma and cystic fibrosis, where the airways may be depleted of SNOs.",
author = "Moya, {Martin P.} and Gow, {Andrew J.} and McMahon, {Timothy J.} and Toone, {Eric J.} and Cheifetz, {Ira M.} and Goldberg, {Ronald N.} and Stamler, {Jonathan S.}",
year = "2001",
month = "5",
day = "8",
doi = "10.1073/pnas.091109498",
language = "English",
volume = "98",
pages = "5792--5797",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "10",

}

TY - JOUR

T1 - S-nitrosothiol repletion by an inhaled gas regulates pulmonary function

AU - Moya, Martin P.

AU - Gow, Andrew J.

AU - McMahon, Timothy J.

AU - Toone, Eric J.

AU - Cheifetz, Ira M.

AU - Goldberg, Ronald N.

AU - Stamler, Jonathan S.

PY - 2001/5/8

Y1 - 2001/5/8

N2 - NO synthases are widely distributed in the lung and are extensively involved in the control of airway and vascular homeostasis. It is recognized, however, that the O2-rich environment of the lung may predispose NO toward toxicity. These Janus faces of NO are manifest in recent clinical trials with inhaled NO gas, which has shown therapeutic benefit in some patient populations but increased morbidity in others. In the airways and circulation of humans, most NO bioactivity is packaged in the form of S-nitro-sothiols (SNOs), which are relatively resistant to toxic reactions with O2/O2 -. This finding has led to the proposition that channeling of NO into SNOs may provide a natural defense against lung toxicity. The means to selectively manipulate the SNO pool, however, has not been previously possible. Here we report on a gas, O-nitrosoethanol (ENO), which does not react with O2 or release NO and which markedly increases the concentration of indigenous species of SNO within airway lining fluid. Inhalation of ENO provided immediate relief from hypoxic pulmonary vasoconstriction without affecting systemic hemodynamics. Further, in a porcine model of lung injury, there was no rebound in cardiopulmonary hemodynamics or fall in oxygenation on stopping the drug (as seen with NO gas), and additionally ENO protected against a decline in cardiac output. Our data suggest that SNOs within the lung serve in matching ventilation to perfusion, and can be manipulated for therapeutic gain. Thus, ENO may be of particular benefit to patients with pulmonary hypertension, hypoxemia, and/or right heart failure, and may offer a new therapeutic approach in disorders such as asthma and cystic fibrosis, where the airways may be depleted of SNOs.

AB - NO synthases are widely distributed in the lung and are extensively involved in the control of airway and vascular homeostasis. It is recognized, however, that the O2-rich environment of the lung may predispose NO toward toxicity. These Janus faces of NO are manifest in recent clinical trials with inhaled NO gas, which has shown therapeutic benefit in some patient populations but increased morbidity in others. In the airways and circulation of humans, most NO bioactivity is packaged in the form of S-nitro-sothiols (SNOs), which are relatively resistant to toxic reactions with O2/O2 -. This finding has led to the proposition that channeling of NO into SNOs may provide a natural defense against lung toxicity. The means to selectively manipulate the SNO pool, however, has not been previously possible. Here we report on a gas, O-nitrosoethanol (ENO), which does not react with O2 or release NO and which markedly increases the concentration of indigenous species of SNO within airway lining fluid. Inhalation of ENO provided immediate relief from hypoxic pulmonary vasoconstriction without affecting systemic hemodynamics. Further, in a porcine model of lung injury, there was no rebound in cardiopulmonary hemodynamics or fall in oxygenation on stopping the drug (as seen with NO gas), and additionally ENO protected against a decline in cardiac output. Our data suggest that SNOs within the lung serve in matching ventilation to perfusion, and can be manipulated for therapeutic gain. Thus, ENO may be of particular benefit to patients with pulmonary hypertension, hypoxemia, and/or right heart failure, and may offer a new therapeutic approach in disorders such as asthma and cystic fibrosis, where the airways may be depleted of SNOs.

UR - http://www.scopus.com/inward/record.url?scp=0035826803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035826803&partnerID=8YFLogxK

U2 - 10.1073/pnas.091109498

DO - 10.1073/pnas.091109498

M3 - Article

C2 - 11320213

AN - SCOPUS:0035826803

VL - 98

SP - 5792

EP - 5797

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 10

ER -